<?xml version="1.0" encoding="UTF-8"?>
<p id="p0105">RAS and ACE2 inhibitors are widely used in treating patients with hypertension. As described earlier ACE2 is the target receptor for SARS-CoV-2 and is highly expressed in epithelial cells in the oral mucosa [
 <xref rid="bb0330" ref-type="bibr">66</xref>]. Additionally, this protein is widely expressed in immune reactive cells such as macrophages, lungs, blood vessels and intestine [
 <xref rid="bb0335" ref-type="bibr">67</xref>]. Clinical findings suggest that circulating ACE2 levels were significantly increased in diabetic and cardiovascular patients, however, this protein is aberrantly expressed with ACE inhibitors Lisinopril alone [
 <xref rid="bb0340" ref-type="bibr">68</xref>].
</p>
